Archive - December 2020
ASH 2020: Gilead eyes new Yescarta indication, Vertex/CRISPR make headway in sickle cell and more
Crescendo Biologics expands Takeda collaboration
FDA set to review GSK’s Nucala for nasal polyps
Enhertu scores ‘impressive’ new data in HER2+ breast cancer
MHRA issues allergy warning for Pfizer/BioNTech COVID-19 jab
FDA briefing document paves the way for Pfizer/BioNTech COVID-19 vaccine approval
bluebird bio’s beta thalassaemia gene therapy Zynteglo scores promising long-term data
Novartis eyes 2021 regulatory submissions for ‘STAMP’ inhibitor asciminib